Research 2006-2007

Continuing:

1. Homocysteine as a marker for male infertility: AIIMS Research Grant, 2006-2007

2. Prevalence of androgen deficiency and sexual function status in the ageing Indian male. Department of Urology, AIIMS

3. Sexual function status of patients before and after treatment of BPH. Department of Urology, AIIMS

4. Evaluation of laparoscopy in the management of carcinoma bladder.

5. Effect of stone and pelvicalyceal system configuration on the morbidity and relook rates with PCNL and its impact on training

6. Development and Validation of a Stratification System to grade the degree of difficulty of PCNL

7. Robotic Surgery

• Laparoscopic Surgery in Urology

1. Genitourinary Cancer (Renal, Bladder and Prostate Cancer)

2. Minimal Invasive Surgery in Urology.

3. Mitochondrial genes and Y chromosome deletions in male infertility. Department of Anatomy, AIIMS, New Delhi:

4. 3 dimensional Chemical shift imaging and Diffusion weighted imaging using Proton MRS in the diagnosis of carcinoma prostate: Department of NMR, AIIMS

5. Stone analysis using x-ray diffraction studies (Biophysics).

6. Prospective randomized study of radical cystectomy versus concurrent chemo-radio-therapy in muscle invasive cancer of urinary bladder (Radiotherapy).

7. Molecular Epidemiology of Prostate Cancer: Polymorphosis inhormone related and prostatic cancer candidate hernes.  ICMR funded project in collaboration with Punjab University Chandigarh and PGI, Chandigarh.

8. Characterisation of Testing Specific Sperm associated antigen 9 (SPAG9) gene expression and humoral immune response in various human cancers: DST funded project in collaboration with National Institute of Immunology, New Delhi and Safdarjung Hospital, New Delhi.

9. Her2/neu over expression and gene amplification in transitional cell carcinoma of urinary bladder. AIIMS reseach fund.

10. Molecular analysis of gene markers in urine cytology and tissue histology specimens of Indian patients with superficial and muscle invasive transitional cell carcinoma of urinary bladder.

11. Multicentre Open-Label, Randomized, phase III trial comparing adjuvant Hormonal Therapy (Eligard-Leuprolide acetate) in combination with Taxotere (docetaxel) versus hormonal therapy alone versus deferred therapy in patients with prostate cancer at High Risk of Relapse after Radical Prostatectomy.

12. Core through urethrotomy with Holmium Yag laser in obliterated traumatic urethral stricture.

13. A Phase IV PMS study of SIIL-ONCO-BCG vaccine administration in patients of superficial bladder carcinoma following TURBT

Completed: 

1. Her2/neu Overexpression and gene implification in transitional cell carcinoma of urinary bladder.

2. “Evaluation of laparoscopic radical cystectomy for carcinoma of bladder”.

3. Comparison of laproscopic and open radical cystectomy for carcinoma of bladder.

4. “Evaluation of laparoscopic radical prostatectomy

5. Comparison of laproscopic and open radical prostatectomy for carcinoma of prostate.

6. Comparison of laproscopic and open radical nephrectomy for renal cancer.